SC 13G | 2024-02-14 | Solas Capital Management, LLC | FENNEC PHARMACEUTICALS INC. | 1,378,513 | 5.2% | EDGAR |
SC 13G/A | 2023-02-14 | Sonic GP LLC | FENNEC PHARMACEUTICALS INC. | 2,407,357 | 9.2% | EDGAR |
SC 13G/A | 2022-02-14 | Sonic Fund II, L.P. | FENNEC PHARMACEUTICALS INC. | 2,407,357 | 9.3% | EDGAR |
SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | FENNEC PHARMACEUTICALS INC. | 1,200,000 | 4.6% | EDGAR |
SC 13G | 2021-02-16 | Sonic Fund II, L.P. | FENNEC PHARMACEUTICALS INC. | 2,433,230 | 9.4% | EDGAR |
SC 13G/A | 2021-02-12 | Avoro Capital Advisors LLC | FENNEC PHARMACEUTICALS INC. | 1,670,000 | 6.5% | EDGAR |
SC 13G/A | 2021-02-12 | Southpoint Capital Advisors LP | FENNEC PHARMACEUTICALS INC. | 4,077,214 | - | EDGAR |
SC 13D/A | 2020-05-04 | Essetifin SPA | FENNEC PHARMACEUTICALS INC. | 3,993,694 | 16.2% | EDGAR |
SC 13G/A | 2019-02-14 | venBio Select Advisor LLC | FENNEC PHARMACEUTICALS INC. | 1,105,999 | 5.6% | EDGAR |
SC 13G/A | 2019-02-14 | 683 Capital Management, LLC | FENNEC PHARMACEUTICALS INC. | 971,351 | 4.9% | EDGAR |
SC 13G/A | 2019-02-14 | Opaleye Management Inc. | FENNEC PHARMACEUTICALS INC. | 9 | 11.0% | EDGAR |
SC 13D/A | 2018-09-10 | MANCHESTER MANAGEMENT PR, LLC | FENNEC PHARMACEUTICALS INC. | 759,584 | 4.0% | EDGAR |
SC 13D/A | 2018-08-17 | MANCHESTER MANAGEMENT PR, LLC | FENNEC PHARMACEUTICALS INC. | 1,038,697 | 5.5% | EDGAR |
SC 13D/A | 2018-06-27 | MANCHESTER MANAGEMENT PR, LLC | FENNEC PHARMACEUTICALS INC. | 1,332,709 | 7.0% | EDGAR |
SC 13G | 2018-06-22 | Opaleye Management Inc. | FENNEC PHARMACEUTICALS INC. | 9 | 11.0% | EDGAR |
SC 13D/A | 2018-05-18 | MANCHESTER MANAGEMENT PR, LLC | FENNEC PHARMACEUTICALS INC. | 1,562,008 | 8.4% | EDGAR |
SC 13D/A | 2018-03-29 | MANCHESTER MANAGEMENT PR, LLC | FENNEC PHARMACEUTICALS INC. | 1,666,666 | 8.7% | EDGAR |
SC 13G/A | 2018-02-14 | 683 Capital Management, LLC | FENNEC PHARMACEUTICALS INC. | 971,352 | 6.1% | EDGAR |
SC 13G | 2018-02-14 | Southpoint Capital Advisors LP | FENNEC PHARMACEUTICALS INC. | 3,997,214 | - | EDGAR |
SC 13G | 2018-02-12 | venBio Select Advisor LLC | FENNEC PHARMACEUTICALS INC. | 1,105,999 | 6.1% | EDGAR |